Medac Gesellschaft für klinische Spezialpräparate mbH (secondary packaging, labeling, quality control and batch release)
UkraineAll drugs from this manufacturer
-
The drug is used for the treatment of epithelial ovarian cancer and small cell lung cancer. It may be used either alone or in combination with other antineoplastic agents.
Dosage form: concentrate for infusion solution
Active substance Dosage carboplatin 10 mg/ml ATC: L01XA02
-
The drug is used for the treatment of malignant metastatic melanoma. It is also used as part of combination therapy for Hodgkin's disease and progressive soft tissue sarcoma in adults.
Dosage form: powder for solution for injection or infusion
Active substance Dosage dacarbazine 100 mg ATC: L01AX04
-
The drug is used for the treatment of malignant metastatic melanoma. It is also prescribed as part of combination therapy for Hodgkin's disease and progressive soft tissue sarcoma in adults.
Dosage form: powder for solution for injection or infusion
Active substance Dosage dacarbazine 200 mg ATC: L01AX04
-
The drug is used for the treatment of malignant metastatic melanoma. It is also prescribed as part of combination therapy for Hodgkin's disease and progressive soft tissue sarcoma in adults.
Dosage form: powder for infusion solution
Active substance Dosage dacarbazine 500 mg ATC: L01AX04
-
The drug is used for the treatment of malignant metastatic melanoma. It is also prescribed as part of combination therapy for Hodgkin's disease and progressive soft tissue sarcoma in adults.
Dosage form: powder for infusion solution
Active substance Dosage dacarbazine 1000 mg ATC: L01AX04
-
The drug is used to treat many types of cancer, including breast, ovarian, stomach, lung, liver, and pancreatic cancer, as well as rectal cancer, and for the treatment of malignant lymphomas, soft tissue sarcoma, and leukemia. When administered intravesically, it is effective against certain types of bladder cancer and for the prevention of its recurrence.
Dosage form: solution for injection
Active substance Dosage epirubicin 2 mg/ml ATC: L01DB03